Blue Bay Ventures is a venture capital firm established in 2021 and based in the Cayman Islands. The firm focuses on investing in early-stage companies, primarily within the technology and blockchain sectors. By concentrating on these innovative areas, Blue Bay Ventures aims to support and foster the growth of emerging businesses that are shaping the future of technology.
Particula is a leading provider of analytics and quality assessment for digital assets, reducing due diligence times and mitigating operational risks for financial leaders. The platform offers advanced risk ratings and comprehensive analyses across technical, economic, environmental, and compliance dimensions. This ensures that investors gain instant security, enhanced market access, and clearer insights. With aggregated on- and off-chain data from diverse sources, Particula transforms investment strategies and streamlines operations.
Brickken
Seed Round in 2025
Brickken offers a comprehensive Digital Asset Suite that enables businesses to create, trade, and manage tokenized financial instruments using blockchain technology. The company provides a no-code solution that simplifies the tokenization process, allowing organizations of any size to enter the blockchain economy without the need for intermediaries. By facilitating the creation, issuance, and management of digital assets in a single platform, Brickken enhances accessibility for investors and promotes a frictionless experience. This approach positions Brickken as a significant player in the emerging Web3 landscape, where it aims to empower companies and investors alike to navigate the tokenization of various assets efficiently.
AccuPulse
Venture Round in 2024
AccuPulse is focused on the development of a pulsed electric field ablation (PFA) system designed to treat atrial fibrillation (A-fib). The company offers a comprehensive solution that includes both a PFA generator and specialized catheters for the pulse ablation of A-fib and tumors. By integrating advanced technologies, AccuPulse aims to enhance catheter localization and signal acquisition, while also improving the overall efficiency of interventional therapies that utilize radio frequency and cryotherapy. This innovative approach seeks to provide healthcare professionals and patients with a more effective and intelligent treatment option for managing A-fib and related conditions.
Guiling Medical
Series A in 2024
Guiling Medical is a medical device company that provides reliable, advanced medical device products for complex wounds and refractory infections
Finoa
Venture Round in 2024
Finoa GmbH, founded in 2018 and based in Potsdam, Germany, provides regulated custody and asset-servicing solutions for digital assets. The company operates a digital asset platform that allows institutional investors and corporations to securely store and manage cryptographic tokens. Finoa's services include custody and staking, designed to accommodate users of varying familiarity with cryptocurrencies. The platform features advanced security measures such as multi-signature processing, biometric fingerprint access, and cryptographically secured private keys. As a qualified custodian supervised by the German Federal Financial Supervisory Authority, Finoa serves a diverse clientele, including venture capital firms, large corporations, and financial institutions, ensuring the safe and intuitive management of digital assets. The company is co-founded by Christopher May and Henrik Gebbing and is supported by several prominent financial investors.
Rouling Technology
Seed Round in 2023
Rouling Technology focuses on the research of non-invasive brain-computer interface technology.
WillVision
Seed Round in 2023
Wellsees is an ophthalmology big data medical technology enterprise. They offer research in ophthalmology and optometry as well as industrial technology research, development, and production, enterprise management, and quality management systems, and characteristics of high-tech medical technology.
Pedo-care
Seed Round in 2023
Jiangsu Pedo-care Medical Equipment Co., Ltd., based in Nantong, China, specializes in the design, manufacture, and sale of medical appliances for children. The company develops a range of products aimed at treating respiratory disorders, including nebulizer masks and nebulizer bottles, which are designed specifically for pediatric use. Pedo-care emphasizes high-quality standards and rigorous research and development, collaborating with prominent universities to enhance its product offerings. The flagship product, a children's nebulizer, adheres to international standards and is known for its safety, ease of use, and durability. By focusing on effective treatments for conditions such as the common cold, fever, cough, asthma, and bronchitis, Pedo-care aims to improve the health outcomes of children.
Kactus Biosystems
Series B in 2022
KACTUS is a biotechnology firm that specializes in the research and development of targeted protein tools. The company provides biotechnology-based services aimed at advancing various applications in the field. Through its innovative approaches, KACTUS seeks to contribute to the development of effective solutions in the biotechnology sector.
Zhihui Medical
Seed Round in 2022
Zhihui Medical is a technology company focused on transforming local scientific research into practical medical solutions for tumor diseases. The company offers integrated medical services that encompass early screening, diagnosis, treatment, and nutritional rehabilitation for cancer patients. It specializes in tumor detection and provides advanced technologies for early cancer detection, immune system activity monitoring, and cancer immunotherapy. Through its innovative approach, Zhihui Medical aims to enhance patient care by facilitating timely interventions and improving treatment outcomes for those affected by cancer.
Security Token Group
Series A in 2022
Security Token Group is a company focused on providing information and resources related to security token offerings (STOs) for the investor community. It offers a platform that facilitates cryptocurrency investments by creating tokenized investment products that are entirely built and managed using blockchain technology. The platform aims to develop refined trading markets that are simple, transparent, and valuable for users, enabling secure participation in security token trading. Originally known as Security Token Partners, the company rebranded to its current name in 2018, reflecting its commitment to advancing the security token market.
DigiShares
Seed Round in 2022
DigiShares offers a comprehensive software solution for the issuance and management of securities on the blockchain, primarily focusing on the tokenization of real estate and other substantial physical assets. As one of the first compliant security token offering platforms in Europe, DigiShares provides a white-label system that includes a user-friendly dashboard for issuers. This dashboard features an automatically updated ownership cap table, ensuring compliance by verifying that buyers are whitelisted before any token trades occur. Investors benefit from a customized KYC/AML process for registration and verification, while issuers can efficiently manage various aspects of their offerings, including share allocations, investor approvals, voting processes, and dividend distributions. DigiShares streamlines the financing and management processes for property developers, asset managers, and investment firms, facilitating quicker, more transparent, and cost-effective transactions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.